Quarter Period Consolidated Statement Of Comprehensive Income

RaQualia Pharma Inc. - Filing #7272582

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Quarter period consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
56,203,000 JPY
JPY
-495,031,000 JPY
56,203,000 JPY
56,203,000 JPY
-431,011,000 JPY
-431,011,000 JPY
-323,662,000 JPY
-431,011,000 JPY
JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-162,335,000 JPY
125,984,000 JPY
Other comprehensive income
-162,335,000 JPY
125,984,000 JPY
Comprehensive income
-657,367,000 JPY
-197,678,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-657,367,000 JPY
-197,678,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.